Elena Nikulina

Bicara Therapeutics Inc. to announce Q2 2026 results and host conference call August 11

Bicara Therapeutics Inc. to announce Q2 2026 results and host conference call August 11
Bicara Q2 2026 earnings call set

Bicara Therapeutics Inc. will release its financial results for the second quarter of 2026 and provide a business update on Tuesday, August 11.

The company will follow the announcement with a conference call scheduled for 8:30 AM ET the same day. Investors and stakeholders can register for the call and access the live webcast through the company's website.

Earlier this year, Bicara Therapeutics appointed Jeremy Bender and Christy Oliger, both with extensive biopharma experience, to its board of directors. The new appointments expanded the company’s leadership team. The company continues to update investors through regular announcements and scheduled calls.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.